Related Experiment Video
Updated: Jul 2, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
miR-184 represses β-catenin and behaves as a skin tumor suppressor
Lubov Turovsky1,2, Ghazal Kheshaiboun1,2, Gharam Yassen1
1Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel.
Abstract:
miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.
Insights
MicroRNA-184 (miR-184) acts as a tumor suppressor in the skin. Its absence promotes skin cancer development by affecting stem cell dynamics and increasing beta-catenin levels.
Area of Science:
- Dermatology
- Molecular Biology
- Oncology
Background:
- MicroRNA-184 (miR-184) is implicated in epidermal stem cell differentiation.
- The role of miR-184 in skin pathology, particularly skin cancer, remains largely undefined.
Purpose of the Study:
- To investigate the function of miR-184 in epidermal stem cell dynamics.
- To determine the role of miR-184 in skin carcinogenesis and squamous cell carcinoma (SCC) development.
Main Methods:
- Utilized miR-184 knockout mice to study epidermal stem cell differentiation and skin carcinogenesis.
- Assessed the impact of miR-184 repression on human SCC cells in vitro and in vivo.
- Analyzed the miR-184 regulatory network and its effect on pro-oncogenic pathways, including beta-catenin signaling.
Main Results:
- miR-184 knockout mice exhibited disrupted epidermal stem cell differentiation and enhanced skin carcinogenesis.
- Repression of miR-184 in human SCC cells promoted neoplastic characteristics and tumor growth.
- miR-184 was found to inhibit pro-oncogenic pathways, cell proliferation, and epithelial-mesenchymal transition.
- miR-184 depletion led to increased beta-catenin levels, and its repression of beta-catenin inhibited the SCC neoplastic phenotype.
Conclusions:
- miR-184 functions as an epidermal tumor suppressor.
- miR-184 plays a critical role in controlling epidermal stem cell homeostasis and preventing skin cancer.
- miR-184 represents a potential therapeutic target for skin squamous cell carcinoma.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Canonical Wnt Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
MicroRNAs

